Aurora Cannabis Inc. (ACB) Q4 2025 Earnings Call Transcript

Aurora Cannabis's Q4 2025 earnings call, held on June 18, 2025, included prepared remarks from CEO Miguel Martin and CFO Simona King, who discussed the company's financial results for the period ending March 31, 2025, with details available on the company's IR website and regulatory filings. The call also included a question-and-answer session with analysts, following a reminder that forward-looking statements are subject to risks and uncertainties detailed in the company's filings.

Analysis

Aurora Cannabis Inc. (NASDAQ:ACB) formally announced its fiscal fourth quarter and full-year 2025 financial results for the period ending March 31, 2025, through an earnings conference call held on June 18, 2025. The call featured presentations from CEO Miguel Martin and CFO Simona King, indicating that key leadership addressed the company's performance and outlook. Crucially, detailed financial statements, Management's Discussion and Analysis (MD&A), and an accompanying news release have been filed and are publicly accessible on the company's investor relations website, as well as via SEDAR+ and EDGAR. The communication included a standard cautionary note regarding forward-looking statements, highlighting potential discrepancies between projections and actual results due to inherent risks and uncertainties. While this announcement confirms the release of critical financial data, the provided excerpt itself does not contain specific performance metrics, earnings figures, or substantive commentary on the company's operational achievements or challenges during the quarter.

Key Decisions for Investors

• Investors should immediately access and thoroughly review Aurora Cannabis's complete Q4 and full-year 2025 financial statements and MD&A, now available on SEDAR+, EDGAR, and the company's IR website, to understand the detailed financial performance and operational developments.
• It is advisable to obtain and analyze the full transcript or replay of the June 18, 2025 earnings call to capture management's detailed commentary, their perspective on the results, the company's future outlook, and responses during the analyst Q&A session.
• Any adjustments to investment positions or outlook for ACB should be carefully considered after a comprehensive evaluation of these newly released financial results and management guidance, in the context of prevailing cannabis sector conditions and individual risk tolerance.